Cosmos Holdings Inc
NASDAQ:COSM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Cosmos Holdings Inc
Net Income (Common)
Cosmos Holdings Inc
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Cosmos Holdings Inc
NASDAQ:COSM
|
Net Income (Common)
-$18.5m
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-41%
|
|
|
Cardinal Health Inc
NYSE:CAH
|
Net Income (Common)
$1.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
|
Henry Schein Inc
NASDAQ:HSIC
|
Net Income (Common)
$398m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
|
Patterson Companies Inc
NASDAQ:PDCO
|
Net Income (Common)
$138.8m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
24%
|
CAGR 10-Years
-4%
|
|
|
Mckesson Corp
NYSE:MCK
|
Net Income (Common)
$4.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
8%
|
|
|
Cencora Inc
NYSE:COR
|
Net Income (Common)
$1.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
Cosmos Holdings Inc
Glance View
Cosmos Holdings, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. The company is headquartered in Chicago, Illinois. The company went IPO on 2010-05-19. The firm imports, exports and distributes pharmaceutical products of brand-name and generic pharmaceuticals, over-the-counter (OTC) medicines, and a variety of dietary and vitamin supplements through its distribution network. The firm operates its business through its subsidiaries: SkyPharm, Decahedron Ltd and Cosmofarm. SkyPharm is principally engaged in creating, developing and trading of its own branded nutraceutical products line, Sky Premium Life. Decahedron is engaged in trading branded and generic pharmaceutical products and medicines across the European Union (EU) member states. Cosmofarm is engaged in distribution of branded pharmaceutical products, OTC products, cosmetics, nursery, and dietary products to pharmacies across Greece. Cosmos Holdings has offices and distribution centers in Thessaloniki, Greece, Athens, Greece and Harlow, United Kingdom.
See Also
What is Cosmos Holdings Inc's Net Income (Common)?
Net Income (Common)
-18.5m
USD
Based on the financial report for Sep 30, 2025, Cosmos Holdings Inc's Net Income (Common) amounts to -18.5m USD.
What is Cosmos Holdings Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-41%
Over the last year, the Net Income (Common) growth was 45%. The average annual Net Income (Common) growth rates for Cosmos Holdings Inc have been 19% over the past three years , and -41% over the past ten years .
